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Background: The invasive treatment of chronic lower extremity peripheral arterial disease (PAD) has become inconsistent.
To standardize treatment at our institution, the Lower Extremity Grading System (LEGS) score was devised, based on
arteriographic findings, symptoms, functional status, comorbid conditions, and technical factors. The scoring system was
used to direct the invasive treatment approach in patients with lower extremity PAD. The purpose of this study was to
prospectively assess outcomes of invasive treatment of lower extremity ischemia as directed by LEGS.
Methods: From March 2002 through December 2002, 332 limbs in 227 patients with indications for intervention were
scored and treated according to the LEGS score and followed for 6 months. Of the 227 patients, 66.1% were male; median
age was 65 years. Diabetes mellitus was present in 44.9% of patients, claudication in 48.5%, and limb-threatening ischemia
in 51.5%. Results of treatment as directed by LEGS were judged with the treatment outcome measures of reconstruction
patency, limb salvage, mortality, change in ambulatory status, change in independent living status, and change in the
short-form health survey (SF-36).
Results: Of 332 limbs, 61.5% with a score of 10 to 19 underwent endovascular therapy; 34% with a score of 0 to 9
underwent open revascularization; and 4.5% with a score greater than 20 underwent primary limb amputation.
Interventions for the entire cohort as directed by LEGS resulted in 6-month primary reconstruction patency of 82.4%;
secondary reconstruction patency, 92.6%; limb salvage, 90%; survival, 89.1%; maintenance of ambulatory status, 85.6%;
maintenance of independent living, 88.4%; and statistically significant improvement in health assessment, regardless of
treatment type, as determined with the SF-36. There was no statistically significant variability when comparing results
according to treatment (open surgery, 0-9 vs endovascular therapy, 10-19) or smaller score group categories (0-5, 6-9,
10-13, 14-19).
Conclusions: At 6 months, treatment as directed by LEGS score resulted in acceptable outcomes. This project is the first
reported prospectively confirmed standardization tool for treatment of lower extremity PAD, and, pending independent
confirmation by others, provides a comparative baseline against which other standardization efforts can be measured. (J
Vasc Surg 2004;39:1268-76.)Management of chronic lower extremity peripheral
arterial disease (PAD) has become progressively more in-
consistent as treatment options and specialists who treat the
disease have increased. While detailed reports such as the
TransAtlantic Inter-Society Consensus (TASC) document
on the treatment of PAD1 attempt to outline what has been
proved and unproved about treatment of atherosclerotic
disease of the lower extremities, recommendations meant
to clarify the most appropriate management are often mit-
igated by the many unsolved critical issues that have yet to
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doi:10.1016/j.jvs.2004.02.0091268be tested. A well-studied treatment algorithm to standard-
ize management would clearly be helpful.
In an attempt to deal with treatment diversity within
our own vascular practice, we developed the Lower Ex-
tremity Grading System (LEGS) score (Fig) as a treatment
standardization tool for lower extremity PAD. This treat-
ment algorithm was developed with evidence-based out-
comes data1 and the collective clinical experience of the
group. We previously reported results of a prospective
study that evaluated the practicality and intergrader consis-
tency of the LEGS score.2 While this study showed LEGS
to be easy to use and relatively immune to intergrader bias,
it did not examine outcomes with LEGS as a treatment
guide. The purpose of the current report therefore is to
provide outcomes after interventional treatment of lower
extremity PAD as prospectively directed by the LEGS
score.
METHODS
LEGS score. The LEGS score was developed at our
institution, with use of evidence-based literature, to recom-
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proach, that is, open surgery versus endovascular interven-
tion versus primary amputation, in patients with medically
refractory, lifestyle-limiting claudication or limb-threaten-
ing ischemia. After institutional review board approval this
prospective study was initiated. To determine a LEGS
score, each symptomatic limb was graded and scored ac-
cording to five clinical categories. The sum of the points
from each category was totaled to derive the LEGS score
for each symptomatic limb. The five categories include the
anatomic disease, based on arteriographic findings; clinical
presentation, that is, claudication or limb-threatening isch-
emia; functional status before intervention; medical comor-
bid conditions; and various technical factors (Fig). Open
surgery is recommended in patients with LEGS scores of 0
to 9, endovascular intervention is recommended for pa-
tients with LEGS scores of 10 to 19, and primary amputa-
tion is recommended for patients with LEGS scores greater
than 20.
Detailed use of the LEGS score, as well as analysis of the
categories involved to derive the score, have been report-
ed.2 In application of the LEGS score it is assumed that
symptomatic PAD is the primary problem and that each
patient has met the standard indication for invasive therapy.
Clinical treatment strategy is initially determined as unilat-
eral or bilateral, because LEGS scoring based on TASC
criteria for aortoiliac disease may change pending involve-
ment of one or both lower extremities. In cases of multi-
Lower Extremity Grading System. TASC, Trans-Atlantic
Redo, repeat.segmental disease, aortoiliac occlusive disease is treated
before infrainguinal disease. If intervention to correct in-
flow disease fails to achieve the desired clinical results, the
affected limb is re-scored, and infrainguinal disease is
treated accordingly.
Study design. From March 1, 2002, through Decem-
ber 31, 2002, 256 consecutive patients with 362 chroni-
cally ischemic legs were treated. Of these, 332 ischemic
limbs in 227 patients were scored with the LEGS score,
treated accordingly, and placed in a strict prospective fol-
low-up protocol: 1 week postoperative, 1 month postoper-
ative, then every 3 months. The study population consisted
of 77 women (33.9%) and 150 men (66.1%). One hundred
ninety-one patients (84.1%) were white, and 36 patients
(15.9%) were African American; mean age was 64.5 11.8
years (median, 65 years; range, 32-94 years). Diabetes was
present in 104 patients (44.9%). One hundred twelve pa-
tients (49.8%) were active smokers, 77 patients (34.2%)
were former smokers, and 36 patients were (16%) non-
smokers. Of the 227 patients who underwent treatment,
110 patients (48.5%) had severe claudication (Rutherford
category 3) and 117 patients (51.5%) had limb-threatening
ischemia (Rutherford category 4 or 5). Each of the 332
limbs was observed for at least 6 months after intervention
or until patient death. The 6-month outcomes of each
intervention were assessed with five clinical measures: arte-
rial reconstruction patency, limb salvage, survival, mainte-
nance or improvement of ambulatory status, and mainte-
society Consensus; Fem-pop-tib, femoral-popliteal tibial;Inter
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addition, the last surviving 105 patients underwent self-
health assessment with the medical outcomes study short-
form health survey (36 items; SF-36)3 before and 6 months
after interventions were performed.
The purpose of this study was to assess outcomes
consequent to using the LEGS score as a treatment algo-
rithm to direct therapy. To do this, we first examined the
overall 6-month outcomes for the entire group. Next we
had planned to examine the outcomes at each individual
LEGS score, to test for statistically significant interscore
variability of results within the system, and thus a potential
flaw in the scoring scale. However, because of non-uniform
distribution of limbs and small sample size within some
individual score categories (Table I), direct comparison for
outcomes at each individual score was not performed.
Therefore, as a surrogate, results from limbs with similar
scores (0-5, 6-9, 10-13, 14-19) were grouped and ana-
lyzed. Results within each of these small group categories
were then statistically compared with each other for vari-
ability. Limbs were also analyzed and compared by type of
treatment (open surgery, 0-9 vs endovascular intervention,
10-19).
Statistical analysis. Reconstruction patency, limb sal-
vage, and survival were assessed with Kaplan-Meier life
table analysis. Survival curves between groups were com-
pared with the log-rank test. Pre-procedure SF-36 health
Table I. Distribution of LEGS scores in 332 limbs
LEGS
score
No. of patients with
each score
No. of patients by
LEGS subcategory
No. of patients
by treatment
2 24 0-5 (n  75) Open surgery
(n  113)
3 7
4 12
5 32
6 6 6-9 (n  38)
7 22
8 5
9 5 Endovascular
intervention
(n  204)
10 36 10-13 (n  147)
11 14
12 18
13 79
14 27 14-19 (n  57)
15 17
16 5
17 4
18 3
19 1 Primary
amputation
(n  15)
22 8 20 (n  15)
23 3
24 2
25 1
33 1
LEGS, Lower Extremity Grading System.survey indices were compared with post-procedure indices
with the one sample t test. The post-procedure SF-36
health survey indices of the open surgery group were com-
pared with the endovascular group with the Student t test
for independent groups. The Fisher exact test was used to
compare proportions, that is, changes in ambulatory status
and independent living status.
RESULTS
None of the 227 patients (332 limbs) were lost to
follow-up. Of the 332 limbs, 113 (34%) had a LEGS score
of 0 to 9, and underwent open surgery; 204 limbs (61.5%)
had a LEGS score of 10 to 19, and underwent endovascular
intervention; and 15 limbs (4.5%) had a LEGS score greater
than 20, and underwent primary limb amputation. The 113
open surgeries included 11 aortobifemoral bypass proce-
dures (22 limbs), two aortobiiliac bypass procedures (four
limbs), two axillobifemoral bypasses (four limbs), three
femorofemoral bypass procedures (three limbs), one uni-
lateral aortofemoral bypass (one limb), and 79 femoropop-
liteal or tibial bypass procedures (74 with autogenous con-
duit, five with polytetrafluoroethylene conduit). Of the 204
endovascular interventions, there were 130 aortoiliac an-
gioplasty procedures, with or without a stent, and 74
femoropopliteal or tibial angioplasty procedures. Sixty-two
of 332 limbs underwent both aortoiliac and infrainguinal
revascularization, performed at the same operative setting
in nine limbs.
Reconstruction patency data
Of the 332 treated limbs, there were 22 early (in-
hospital, 30 days) revascularization failures, including
nine femoropopliteal or tibial bypass graft thromboses,
confirmed at physical examination, duplex ultrasound
scanning, or arteriography, and 13 failed angioplasty pro-
cedures, as determined by deterioration to preinterven-
tional ankle-brachial index or detection at direct duplex
ultrasound scanning. Sixteen of the 22 failed recon-
structions were immediately salvaged for secondary pa-
tency, including seven of nine failed bypass grafts and
six of 13 failed angioplasty procedures. Failed revascular-
izations were managed at the discretion of the treating
surgeon. All failed angioplasty procedures were salvaged
with endovascular means, and all failed open surgical
procedures were salvaged with open surgery. The 180-day
primary and secondary patency data for the 317 limb
revascularizations, excluding the 15 primary amputations,
are shown in Table II. The overall 6-month primary pa-
tency and secondary patency rates, as determined with
Kaplan-Meier life table analysis, were 82.4% and 92.6%,
respectively. There was no significant difference in
reconstruction patency rate between limbs selected with
LEGS for open surgery (score 0-9) and limbs selected for
angioplasty (score 10-19). Furthermore, subgroup
comparison of limbs with scores from 0 to 5, 6 to 9, 10 to
13, and 14 to 19 showed no significant difference between
any groups.
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Overall limb salvage after revascularization, excluding
the 15 primary amputations, and limb salvage stratified by
presentation at 6 months, as determined with life table
analysis, is shown in Table III. Limb salvage at 6 months for
the entire group was 90.0%. There was no significant dif-
ference in limb salvage between the open surgery group
(score 0-9) and the endovascular intervention group (score
10-19), regardless of presentation. In addition, subgroup
comparison of limbs with scores of 0 to 5, 6 to 9, 10 to 13,
and 14 to 19 showed no statistically significant limb salvage
differences between any groups.
Survival
Twenty-four patients died during the 6-month study
period, yielding an overall 6-month Kaplan-Meier survival
rate of 89.1%. These included eight early deaths, three after
open surgery, three after angioplasty, and two after primary
amputation. Survival for the entire group (n  227) is
Table II. Primary and secondary arterial reconstruction pa
Group
No. of
limbs
Primary patenc
at 180 days (%)
All (scores 0-19) 317 82.4
Open surgery (scores 0-9) 113 78.6
Endovascular (scores 10-19) 204 84.4
P† .28
LEGS score
0-5 75 76.5
6-9 38 82.8
10-13 147 85.5
14-19 57 81.2
P† .41
LEGS, Lower Extremity Grading System.
*Kaplan-Meier life-table analysis.
†Log-rank test.
Table III. Limb salvage at 180 days*
Group
Overall series
No. of
limbs
Intact
limbs
(%) 95%
All (scores 0-19) 317 90.0 86.7,
Open surgery (scores 0-9) 113 93.8 89.1,
Endovascular (scores 10-19) 204 94.4 91.2,
P† .85
LEGS score
0-5 75 95.5 90.5,
6-9 38 90.1 79.5,
10-13 147 95.8 92.5,
14-19 57 90.7 82.9,
P† .90
LEGS, Lower Extremity Grading System; CI, confidence interval.
*Kaplan-Meier life-table analysis.
†Log-rank test.shown in Table IV. Patients with more than one LEGS
score were assigned the highest LEGS score for purposes of
analysis. There was no survival difference in the open sur-
gical group versus the endovascular intervention group.
Furthermore, subgroup analysis showed no difference in
survival between patients with score groups of 0 to 5, 6 to
9, 10 to 13, and 14 to 19. However, six of 12 patients with
scores greater than 20 and who underwent primary ampu-
tation died within 6 months, a difference that was signifi-
cantly higher when compared with the remaining cohort.
Quality of life
Change in ambulatory status. The 12 bedridden
patients with scores of 20 or greater and who underwent
primary amputation were excluded from analysis of change
in ambulatory status. Again, patients with more than one
LEGS score were grouped according to highest LEGS
score. Change in ambulatory status is shown in Table V. A
change in ambulatory status was defined as a change in
y at 180 days*
95% Confidence
interval
Secondary patency
at 180 days (%)
95% Confidence
interval
78.1, 86.7 92.6 89.7, 95.6
70.6, 86.6 93.9 89.1, 98.6
79.3, 89.4 91.9 88.1, 95.7
.35
66.3, 86.7 95.5 90.5, 100
70.3, 95.4 90.7 80.6, 100
79.7, 91.2 92.4 88, 96.7
70.7, 91.7 90.6 82.7, 98.4
.70
Limbs treated for
claudication
Limbs treated for
limb-threatening
ischemia
No. of
limbs
Intact
limbs
(%)
No. of
limbs
Intact
limbs
(%) 95% CI
172 100 145 87.2 81.5, 92.9
62 100 51 89.3 80.4, 98.2
110 100 94 86.2 78.9, 93.5
1.00 .39
37 100 38 91.4 82.2, 100
25 100 13 83.3 62.2, 100
83 100 64 91.7 84.8, 98.6
27 100 30 74.0 57.3, 90.7
1.00 .45tenc
yCI
93.3
98.6
97.6
100
100
99.1
98.5
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terized by the categories in the Fig. Of the 215 patients,
184 (85.6%) were able to maintain or improved ambulatory
status at 6 months. A comparison of open surgery (score
0-9) and endovascular intervention (score 10-19) at 6
months revealed no advantage for either treatment
method. Subgroup comparison showed no significant dif-
ference in ambulatory status among patients with scores of
0 to 5, 6 to 9, 10 to 13, and 14 to 19. Although all patients
treated for claudication improved ambulation, only three
patients in the entire group actually changed functional
classification category. When comparing patient limbs with
claudication with patient limbs with limb-threatening isch-
emia, 97.2% of patients with claudication maintained am-
bulation, compared with 74.3% of patients with limb-
threatening ischemia (P  .001). Also noteworthy is that
five patients with a failed vascular reconstruction who sub-
sequently underwent below-knee amputation were ambu-
latory with a below-knee limb prosthesis at 6 months.
Change in living status. In the analysis, patients were
categorized, in decreasing order of independence, as living
independently at home; living in an assisted-living facility,
that is, a communal facility that provides meals and social
activities but allows on-campus, private dwelling; or living
in a total-care nursing facility. As with change in ambula-
tory status, the 12 bedridden patients who underwent
primary amputation were excluded from analysis, and pa-
tients were grouped according to highest LEGS score. The
change in living status in the remaining 215 patients is
shown in Table V. At 6 months, 190 patients (88.4%) who
underwent intervention maintained their living status, and
25 patients (11.6%) died or their independent living status
deteriorated. There was no significant difference in change
of living status between patients who underwent open
surgery (score 0-9) versus those who underwent endovas-
cular intervention (score 10-19). Nor was there any signif-
icant difference among LEGS score groups 0 to 5, 6 to 9,
Table IV. Survival at 180 days*
Group
No. of
patients
Alive at
180 days
(%)
95%
Confidence
interval
All (scores 0-20)† 227 89.1 84.9, 93.2
Open surgery (scores 0-9)† 68 92.3 85.9, 98.8
Endovascular (scores 10-19) 147 90.9 86.2, 95.6
P .94
LEGS score†
0-5 44 93.0 85.4, 100
6-9 24 91.3 79.8, 100
10-13 104 93.1 88.2, 98.1
14-19 43 85.2 74.2, 96.2
P .94
LEGS score 20† 12 50.0 21.7, 78.3
P .001
LEGS, Lower Extremity Grading System.
*Kaplan-Meier life table analysis.
†Patients with more than one LEGS score were assigned the highest score
for analysis.10 to 13, and 14 to 19. When comparing limbs with
claudication with limbs with limb-threatening ischemia,
97.2% of patients with claudication maintained indepen-
dent living status, compared with 81.9% of patients with
limb-threatening ischemia (P  .001).
SF-36 health assessment survey
The last 105 patients entered in this prospective trial
were administered the SF-36 health survey (Physical Func-
tion, Role Physical, Bodily Pain, General Health, Vitality,
Social Function, Role Emotional, Mental Health, Physical
Component Summary, and Mental Component Sum-
mary), before and after intervention, by a research assistant
not involved in the direct care of the patient. There was
statistically significant improvement in essentially all areas
of the examination at 6 months after intervention (Table
VI). These improvements occurred regardless of treatment,
whether open surgery or endovascular intervention (Table
VII). A post-procedural comparison of survey scores be-
tween patients undergoing open surgery versus endovascu-
lar intervention showed no statistical advantage for either
therapy; open surgery versus endovascular intervention
score differences for the eight SF-36 test areas ranged from
0.92 to 1.33; P  0.56 to 0.97.
Analysis of outcomes by clinical presentation
Of 332 limbs, 172 had claudication (Rutherford cate-
gory 3) and 160 had critical limb ischemia (Rutherford
category 4 or 5). Of limbs with critical ischemia, 15 limbs
were amputated, leaving 145 limbs for analysis. When
assessing outcomes by presentation, that is, claudication
versus limb-threatening ischemia, patients with claudica-
tion treated according to LEGS had significantly better
primary patency (93.9% vs 68.5%; P  .001), limb salvage
(100% vs 79%; P  .001). and patient survival (96.3% vs
81.1%; P .004). As well, patients treated for claudication
had significantly better post-treatment functional out-
comes for maintenance of ambulation, independent living
status, and SF-36 health assessment, compared with pa-
tients treated for limb-threatening ischemia. However,
when comparing type of treatment, that is, open surgery
versus endovascular intervention, there was no significant
difference in 6-month outcomes for patency, limb salvage,
maintenance of ambulation status, or SF-36 health assess-
ment, regardless of presentation.
DISCUSSION
The purpose of this study was to provide outcomes data
for intervention of chronic lower extremity PAD with
LEGS as a prospective treatment guide. This is the second
prospective report from our institution using the LEGS
score. Our report in June 2003 introduced the concept of
the LEGS score, demonstrated its use, and showed that
scoring consistency is possible, even with graders who have
differing perspectives regarding treatment of PAD.2 The
current report looks at traditional outcome measures, such
as reconstruction patency, mortality, and limb salvage, as
well as patient well-being and functional status, such as
JOURNAL OF VASCULAR SURGERY
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using LEGS to prospectively direct care. Future work will
examine how implementation of a standardization tool to
direct therapy of lower extremity PAD, such as the LEGS
score, will affect outcomes compared with other methods
used to decide treatment. Before analyzing the findings of
Table V. Change in amabulatory and independent living s
Group
No. of
patients* Mortality (%)
Improved
maintain
ambulati
(%)
Overall 215 8.4 85.6
Open surgery
(scores 0-9)
68 7.4 83.8
Endovascular
(scores 10-19)
147 8.8 86.4
LEGS score
0-5 44 6.8 86.4
6-9 24 8.3 83.4
10-13 104 6.7 89.4
14-19 43 13.9 81.4
LEGS, Lower Extremity Grading System.
*Excludes patients with primary amputation.
Table VI. Overall results of pretreatment and posttreatme
Pretreatment
Physical Function 27.6  9.4
Role Physical 30.3  11.4
Bodily Pain 34.7  9.2
General Health 38.3  10.9
Vitality 41.4  12.3
Social Function 36.7  14.6
Role Emotional 39.5  17
Mental Health 44.5  14.2
Table VII. Results of SF-36 health survey before and after
Pre-procedure
Open surgery (N  33 patients)
Physical Function 25.5  9.1
Role Physical 27.6  9.4
Bodily Pain 32.3  8.7
General Health 34.7  9.9
Vitality 39.1  10.9
Social Function 32.9  12.5
Role Emotional 36.2  17.4
Mental Health 44.5  13.7
Endovascular intervention (N  72 patients)
Physical Function 28.5  9.4
Role Physical 31.6  12.0
Bodily Pain 35.8  9.3
General Health 39.9  11.0
Vitality 42.4  12.9
Social Function 38.5  15.3
Role Emotional 41.0  16.6
Mental Health 44.5  14.5this study we found it helpful to first articulate what we
were trying to achieve by using the LEGS score, and second
to determine the characteristics of a “perfect” standardiza-
tion tool for PAD. In this regard, the goal of the LEGS
score was to take a heterogenous group of patients with
diverse problems at presentation, filter them through a
at 180 days
Decline in
ambulation
(%) P
Retained
independent
living (%)
Decline in
independent
living (%) P
6.0 88.4 3.2
8.8 91.2 1.5
.86 .9
4.8 87.1 4.1
6.8 90.9 2.3
8.3 .51 91.7 0 .22
3.9 90.4 2.9
4.7 79.1 7.0
-36 health survey in 105 patients
ttreatment Difference P
.8  14.3 7.2 .001
.1  13.6 6.8 .001
.9  11.9 9.2 .001
.4  12.0 2.1 .051
.8  12.6 6.4 .001
.0  13.1 7.3 .001
.2  14.5 4.7 0.007
.2  12.0 4.7 .001
n surgery and before and after endovascular intervention
st-procedure Difference P
4.6  15.8 9.2 .002
7.3  15.2 9.7 .002
4.9  13.9 12.6 .001
0.8  12.7 6.1 .008
7.2  12.7 8.0 .001
5.2  13.1 12.4 .001
4.8  14.4 8.6 .006
8.6  12.3 4.2 .08
4.8  13.7 6.3 .001
7.0  12.9 5.5 .001
3.4  10.9 7.6 .001
0.2  11.7 0.3 .79
8.1  12.6 5.7 .001
3.5  13.1 5.0 .002
4.0  14.7 3.0 .16
9.4  12.0 4.9 .002tatus
or
ed
onnt SF
Pos
34
37
43
40
47
44
44
49ope
Po
3
3
4
4
4
4
4
4
3
3
4
4
4
4
4
4
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sults. A perfect treatment algorithm would be expected to
achieve acceptable outcomes compared with established re-
ported outcomes; produce minimal outcomes variability
among treatment arms of the algorithm, or individual score
categories as it applies to LEGS, a finding that would expose
an obvious flaw in the algorithm; and offer each individual
patient the treatment that would result in the best outcomes
when compared with all other treatments available.
The findings show that treatment as directed with
LEGS produced similar results for secondary patency, limb
salvage, and survival, as reported by the TASC document,
that is, percutaneous intervention for aortoiliac and femoral
PAD with patency rates of 90% and 61%, respectively, at 1
year, regardless of indication; surgical bypass with 1-year
secondary patency or limb salvage rates of 90% and 80% to
90% for claudication and limb-threatening ischemia, re-
spectively.4 This report also found no statistically significant
variability in outcomes when comparing type of treatment
(open surgery vs endovascular intervention) or comparing
smaller LEGS score subcategories (0-5, 6-9, 10-13, 14-
19). More than 85% of study participants maintained am-
bulation and independent living status at 6 months, includ-
ing five patients who were ambulatory with a prosthesis
after limb amputation, and SF-36 health assessment scores
improved in every category. The LEGS score appears to
have effectively accomplished the goal of taking a heterog-
enous population and directing treatment such that accept-
able homogenous outcomes occurred. Our enthusiasm,
however, must be tempered, because this study did not
attempt to address the third, and arguably most important,
characteristic of the “perfect” standardization tool, that is,
the ability to predict treatment that would result in the best
outcomes compared with all other treatments available. To
determine whether the LEGS score is capable of defining
best treatment is beyond the ability of most single institutions,
including ours. We are therefore forced to conclude that the
LEGS score as a treatment standardization tool shows prom-
ise and is worthy of further study by other groups.
Paramount for appreciation of our LEGS score research
is belief that an algorithm to standardize treatment of
invasive intervention for lower extremity PAD is desirable.
While this has been intuitively accepted by the investigators
of this report, we have not found universal agreement.
Treatment algorithms, care maps, and evidence-based de-
cision analysis have become increasingly popular in other
areas of medicine. They have repeatedly been shown to be
effective in improving technical quality of care and lowering
cost.5 While it would stand to reason that the treatment of
PAD would lend itself to such an algorithm, to date no
effective universally accepted treatment algorithm has
emerged. Despite this, several decision analysis models for
PAD have been proposed.6-8 These include models based
on classification tree analysis, computational internet-based
techniques, and the Markov process. Each has been tested
only with retrospective case review or simulated computer
data. None has gained popularity in the clinical practice of
vascular surgery. Despite this, we contend that a usabletreatment algorithm for PAD is long overdue, and has a
potential place in the delivery of care.
Refined reporting standards are also needed for re-
search and outcomes study of PAD. It has been 6 years
since Rutherford et al9 published their recommended stan-
dards for reports dealing with lower extremity ischemia.
While this important work is commonly cited, it is limited
by its focused approach to limb ischemia. Specifically, in
their reporting standards the authors fail to take into con-
sideration the overall condition of the patient. This can
result in inappropriate comparisons between study popula-
tions. For example, is it reasonable to compare the out-
comes of treatment for two patients with Rutherford cate-
gory 4 limb ischemia when one patient is a severely
hampered, but working, ambulatory 50-year-old and the
other is an 80-year-old wheelchair-bound contralateral am-
putee? Clearly something like the LEGS score can consider
the overall preoperative functional status of the patient, to
provide better population comparison, especially when an-
alyzing functional outcomes data for the treatment of our
aging, progressively more complex patient population with
PAD.
Last, standardization is needed to address the increas-
ing “cognitive vacuum” that has emerged since multiple
specialists have chosen to enter the realm of PAD treat-
ment. Whether vascular surgeons, cardiologists, vascular
internists, cardiac surgeons, radiologists, or general sur-
geons, their treatment of lower extremity PAD has become
segmented and often dictated by educational bias and the
technical skills of the treating physician (endovascular vs
open surgery vs both). Despite being a group of 10 vascular
specialists who consider ourselves academically oriented,
we discovered in our practice that patients are often offered
specific treatments on the basis of which physician they see
(eg, endovascular specialist or open surgical specialist), not
by which treatment had the best predicted outcomes.
When we realized this, the LEGS project was initiated.
Since its publication the LEGS score has been both
praised and criticized. We accept the criticism that because
this scale was devised and tested by the same single group of
specialists, intrinsic bias may be present in the algorithm. It
clearly needs to be tested by others before clinical applica-
tion should be considered. Other criticism involves dis-
agreement about the actual components of the LEGS score
categories. Common objections to our LEGS score ap-
proach include mixing of treatments and lack of stratifica-
tion (eg, grouping of limb salvage surgery, claudication,
aortoiliac occlusive disease, infrainguinal disease, vein con-
duits, artificial conduits), which makes comparative analysis
with current published data difficult; failure to include
end-stage renal disease in the treatment algorithm; “inap-
propriate” inclination toward endovascular therapy or to-
ward open surgery, depending on one’s perspective; and
“inappropriate” direction of patients at higher risk toward
endovascular surgery and patients at low risk to open
surgery. While we concede that the LEGS score is imper-
fect, the system was developed on several basic principles.
First, endovascular therapy and open surgical therapy
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complementary treatments. We developed the scale with
factors we believed would clearly tip the preferred ther-
apy toward one method or the other in the best interests
of the patient. Factors that we believed were neutral to
the type of therapy used were not incorporated into the
score. For example, while numerous studies show that
chronic renal failure negatively affects treatment of lower
extremity ischemia,10-13 it is unclear whether it affects
open surgery more negatively than endovascular inter-
vention, or vice versa. Therefore, while we acknowledge
that renal failure and especially end-stage renal disease
are problematic, we limited the role of renal failure,
except in dialysis-dependent patients with heel ulcers, as
an influence toward a specific treatment. The LEGS
algorithm was established with the belief that younger,
healthier patients will live longer, can better tolerate
more invasive procedures, need durable reconstructions,
and thus should undergo open surgery. Conversely,
patients at the opposite presentation spectrum should
undergo endovascular intervention. While the LEGS
score has provided a reasonable standardization method
for our group, follow-up is short and the score has yet to
be tested by an outside group of vascular specialists,
clearly significant limitations that need to be reconciled
before general acceptance.
In conclusion, the LEGS score represents the first
reported prospectively confirmed standardization tool for
treatment of lower extremity PAD. Therapy as directed
with LEGS compares favorably with accepted established
outcomes for reconstruction patency, limb salvage, sur-
vival, and functional well-being. While further independent
study is needed, the findings of this report are encouraging,
and suggest that a system such as LEGS, if not LEGS itself,
can evolve into an important management tool, or at leastprovide a comparative baseline against which other stan-
dardization efforts can be measured.
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Available online Apr 28, 2004.DISCUSSIONDr Brad Johnson (Tampa, Fla). First, have you presented, or
do you plan to present, this to your hospital medical staff as a
system that all medical specialists—cardiologists, surgeons, and
interventional radiologists—would use as a system to treat periph-
eral vascular disease?
Second, I was impressed not only with your assessment of graft
patency and limb salvage, which showed good outcomes, but also,
more importantly, your assessment of living status and health assess-
ment after open endovascular repair. I was somewhat surprised,
though, that there was no difference in open surgery and endovas-
cular repair with regard to bodily pain ot physical results. My
patients, especially after lower limb revascularization, have a lot of
complaints. How can you explain this, for this would be important
information to present to patients prior to their treatment?
Dr Spence M. Taylor. We have been spending more time
trying to prove the worthiness of this as opposed to presenting it as
the gospel truth, and so we have not gone to the medical staff. But
clearly the idea of this whole project is based on diversity of
treatment by multiple specialists, namely, cardiologists, radiolo-gists, and, sadly even, within our own group. The thing that started
this entire project was the realization that if a patient was
referred to our practice and I saw the patient, I would offer a
different treatment than, let’s say, Bruce Gray, who does mostly
endovascular intervention. So we felt that was intrinsically
wrong—that is, if a patient comes to your group you ought to
have consistent treatment and that’s what started this project
almost 3 years ago.
This is a prospective study, so the results are the results. You
get what you get—the SF-36 data were administered by Corey
Kalbaugh, the first author on this paper, who is a graduate student
at Clemson, and the results were surprising. We were surprised as
well. Clearly, people were “up and at ‘em” a little bit more quickly,
and I don’t know whether that is a placebo effect or whether
patients are making the best of the decisions they make in terms of
treatment, or whather they are optimistic, but we were somewhat
surprised. But the results are what they are.
Dr G. Patrick Clagett (Dallas, Tex). What happened to
medical therapy in this algorithm? The patient that you showed
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with stop smoking and exercising.
Dr Taylor. You only get scored in the leg score after you fail
medical therapy. This is simply an invasive treatment. None of
these patients were operated on without medical treatment andthat needs to be underscored. After you have made the decision
that indeed you are going to treat these people invasively they get
a leg score and then you up front decide whether you are going to
treat them bilaterally or unilaterally and then we proceed inflow
over outflow and score limbs accordingly. That’s a good point.
